Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease

Fig. 4

Proportion of patients with Hb ≥110 g/L before and after IIM – patients not receiving ESA at baseline.

*p < 0.05 versus ≤1000 mg; statistical analyses comparing higher and lower dose groups were performed for baseline and Course 1 only.

ESA erythropoiesis-stimulating agent, Hb haemoglobin, n number of patients with data

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us